Capstone Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$266K Sell
5,226
-400
-7% -$19.8K 0.01% 1347
2017
Q1
$250K Sell
5,626
-790
-12% -$34K 0.01% 1411
2016
Q4
$283K Sell
6,416
-1,950
-23% -$82.8K 0.01% 1353
2016
Q3
$335K Sell
8,366
-130
-2% -$5.52K 0.01% 1246
2016
Q2
$406K Buy
8,496
+500
+6% +$21.2K 0.01% 1089
2016
Q1
$335K Sell
7,996
-460
-5% -$18.1K 0.01% 1197
2015
Q4
$372K Sell
8,456
-110
-1% -$4.77K 0.01% 1117
2015
Q3
$409K Buy
8,566
+280
+3% +$15.4K 0.01% 1046
2015
Q2
$483K Sell
8,286
-4,190
-34% -$226K 0.01% 987
2015
Q1
$630K Buy
12,476
+1,130
+10% +$55.4K 0.02% 930
2014
Q4
$510K Sell
11,346
-660
-5% -$27.7K 0.01% 1039
2014
Q3
$442K Sell
12,006
-270
-2% -$10.7K 0.02% 1090
2014
Q2
$542K Buy
12,276
+1,942
+19% +$88.1K 0.02% 1001
2014
Q1
$449K Sell
10,334
-800
-7% -$35.7K 0.01% 1145
2013
Q4
$473K Sell
11,134
-2,054
-16% -$78K 0.01% 1170
2013
Q3
$448K Buy
13,188
+240
+2% +$7.83K 0.01% 1376
2013
Q2
$404K Buy
+12,948
New +$420K 0.01% 1363

Other funds holding CNMD

Capstone Asset Management's CNMD Position: Q2 2017 in Review

Capstone Asset Management reduced its CONMED (CNMD) stake by 7.1% in Q2 2017, selling an estimated $19.8K and leaving 5,226 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1347.

Capstone Asset Management first reported a position in CNMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $630K in Q1 2015. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.

  • Capstone Asset Management held 5,226 shares of CONMED worth $266K as of Q2 2017.
  • Capstone Asset Management sold 400 CONMED shares in Q2 2017, an estimated $19.8K.
  • CONMED made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1347 holding.
  • Capstone Asset Management first reported a position in CONMED in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's CONMED position peaked at $630K in Q1 2015.
  • 150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.